China Resources Pharmaceutical Group Limited (HKG:3320)

Hong Kong · Delayed Price · Currency is HKD

5.64

+0.31 (5.82%)

At close: Mar 27, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Manufacturing		46.32B	43.46B	38.03B	31.46B	27.12B
Manufacturing Growth		6.58%	14.28%	20.90%	16.00%	-10.26%
Distribution		213.24B	202.15B	181.42B	162.22B	142.16B
Distribution Growth		5.48%	11.43%	11.83%	14.11%	-6.83%
Elimination of Inter-Segment Sales		-12.07B	-10.57B	-8.89B	-7.09B	-6.15B
Others		73.58M	76.36M	35.02M	133.55M	190.29M
Others Growth		-3.64%	118.04%	-73.78%	-29.82%	3.95%
Retail		10.10B	9.58B	7.59B	6.20B	5.45B
Retail Growth		5.48%	26.24%	22.46%	13.78%	-5.74%
Total		257.67B	244.70B	218.18B	192.92B	168.76B
Total Growth		5.30%	12.16%	13.10%	14.31%	-7.66%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Mainland China		256.14B	243.11B	216.95B	192.41B	168.21B
Mainland China Growth		5.36%	12.06%	12.76%	14.39%	-7.54%
Others		1.54B	1.59B	1.23B	-	-
Others Growth		-3.35%	29.13%	-	-	-
Hong Kong		-	-	-	512.25M	557.89M
Hong Kong Growth		-	-	-	-8.18%	-34.51%
Total		257.67B	244.70B	218.18B	192.92B	168.76B
Total Growth		5.30%	12.16%	13.10%	14.31%	-7.66%

Source: S&P Global Market Intelligence.